Pacritinib — Carefirst Caremark
5 indications indexed for this drug.
- Accelerated Phase Or Blast Phase Myeloproliferative NeoplasmView coverage criteria
- Intermediate Or High Risk Primary Or Secondary Post PolycythView coverage criteria
- Mf Associated AnemiaView coverage criteria
- Symptomatic High Risk MfView coverage criteria
- Symptomatic Low Risk Mf With Platelet Count 50 10 9 LView coverage criteria